Follow
Rosa Bernardi
Rosa Bernardi
San Raffaele Scientific Insitute
Verified email at hsr.it
Title
Cited by
Cited by
Year
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
R Bernardi, PP Pandolfi
Nature reviews Molecular cell biology 8 (12), 1006-1016, 2007
11102007
Role of nucleophosmin in embryonic development and tumorigenesis
S Grisendi, R Bernardi, M Rossi, K Cheng, L Khandker, K Manova, ...
Nature 437 (7055), 147-153, 2005
7082005
PML targeting eradicates quiescent leukaemia-initiating cells
K Ito, R Bernardi, A Morotti, S Matsuoka, G Saglio, Y Ikeda, J Rosenblatt, ...
Nature 453 (7198), 1072-1078, 2008
6862008
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
R Bernardi, I Guernah, D Jin, S Grisendi, A Alimonti, J Teruya-Feldstein, ...
Nature 442 (7104), 779-785, 2006
4762006
PML regulates p53 stability by sequestering Mdm2 to the nucleolus
R Bernardi, PP Scaglioni, S Bergmann, HF Horn, KH Vousden, ...
Nature cell biology 6 (7), 665-672, 2004
4442004
PML regulates apoptosis at endoplasmic reticulum by modulating calcium release
C Giorgi, K Ito, HK Lin, C Santangelo, MR Wieckowski, M Lebiedzinska, ...
Science 330 (6008), 1247-1251, 2010
4302010
Loss of the tumor suppressor PML in human cancers of multiple histologic origins
C Gurrieri, P Capodieci, R Bernardi, PP Scaglioni, K Nafa, LJ Rush, ...
Journal of the National Cancer Institute 96 (4), 269-279, 2004
4242004
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction
S Fumagalli, A Di Cara, A Neb-Gulati, F Natt, S Schwemberger, J Hall, ...
Nature cell biology 11 (4), 501-508, 2009
3822009
Role of PML and the PML-nuclear body in the control of programmed cell death
R Bernardi, PP Pandolfi
Oncogene 22 (56), 9048-9057, 2003
2692003
Regulation of apoptosis by PML and the PML-NBs
R Bernardi, A Papa, PP Pandolfi
Oncogene 27 (48), 6299-6312, 2008
1842008
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase–mediated mTOR activation in tuberous sclerosis and human cancer
LI Ma, J Teruya-Feldstein, P Bonner, R Bernardi, DN Franz, D Witte, ...
Cancer research 67 (15), 7106-7112, 2007
1642007
Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia
D Magliulo, R Bernardi, S Messina
Frontiers in oncology 8, 255, 2018
952018
Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation
R Bernardi, DA Liebermann, B Hoffman
Oncogene 19 (20), 2447-2454, 2000
922000
Multiparametric staining to identify apoptotic human cells
C Negri, M Donzelli, R Bernardi, L Rossi, A Bürkle, AI Scovassi
Experimental cell research 234 (1), 174-177, 1997
841997
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia
C Gurrieri, K Nafa, T Merghoub, R Bernardi, P Capodieci, A Biondi, ...
Blood 103 (6), 2358-2362, 2004
822004
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
P Salomoni, R Bernardi, S Bergmann, A Changou, S Tuttle, PP Pandolfi
Blood 105 (9), 3686-3690, 2005
732005
The nucleolus: at the stem of immortality
R Bernardi, PP Pandolfi
Nature medicine 9 (1), 24-25, 2003
722003
The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence
K Cheng, S Grisendi, JG Clohessy, S Majid, R Bernardi, P Sportoletti, ...
Oncogene 26 (53), 7391-7400, 2007
712007
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment
R Valsecchi, N Coltella, D Belloni, M Ponente, E Ten Hacken, C Scielzo, ...
Blood, The Journal of the American Society of Hematology 127 (16), 1987-1997, 2016
682016
Hallmarks of triple negative breast cancer emerging at last?
R Bernardi, L Gianni
Cell research 24 (8), 904-905, 2014
652014
The system can't perform the operation now. Try again later.
Articles 1–20